Twitter Beğeni Hilesi

What a great way to start off our morning! This was really an honor for me to moderate this session with these rock ⭐️ women in liver cancer who are advocating for their voices and our patients - HCC-LIVE Conference Kirema Garcia-Reyes, MD Julie Heimbach Laura Dawson #lipikagoyal #reenasalgia

Biomarkers in #HCC and treatment response Tim Greten makes it easy to understand 👇🏼 HCC-LIVE Conference #livertwitter

Hot topics panel discussion is now live🔥

Abstract 4 'Clinical Impact of Ceus on Indeterminate Liver Nodules on MRI: Sub-Analysis From a Prospective Multicenter Trial' with Yoko Kono, MD, PhD, FAIUM, FAASLD at #Hcclive2024 #LiverTwitter

'Patient-Reported Outcomes (Pros) From the Phase 3 Cares-310 Trial of Camrelizumab + Rivoceranib vs Sorafenib as First-Line Treatment for Patients With Unresectable Hepatocellular Carcinoma' with Stephen Chan, MD. is now happening at #HccLive2024

Abstract 17 'Single Center Experience With Liver Transplantation for Cholangiocarcinoma Suggests Improved Outcomes With Intra-Hepatic Cancers and With mTOR Inhibition' with Ashton Connor, MD, PhD🗣️

Thank you HCC-LIVE Conference for another incredible event. #HCCLIVE has the perfect mix of high-level, relevant, education and vibrant discussion - all with the most collegial vibe. This is where #HCC ideas are born. Looking forward to next year!

An amazing debate one Moderated by Anjana Pillai and Neehar Parikh "Is Emerald Practice Changing?" between Richard Finn, MD; and David James Pinato 🇺🇦!🗯️

Thank you HCC-LIVE Conference and Anjana Pillai for the invitation. Enjoyed all the talks, debates, MDT discussions and the opportunity to hear from an all ⭐️ panel on mentorship and how to support women in medicine Kudos to the organizers 👏🏼👏🏼👏🏼👏🏼 For more women in hepatology,

"TARE vs. Surgery for VP1 HCC" between Kirema Garcia-Reyes, MD; and Karim Halazun, MD, FACS. Don't miss this opportunity to hear expert opinions and engage in this critical conversation! Kirema Garcia-Reyes, MD Karim J Halazun MD

Our final debate is now commencing - Join Laura Dawson, MD; Laura Dawson and Josep Llovet, MD, PhD, FAASLD as they debate "SBRT Should be Included in HCC Guidelines – Definitely Yes vs. Not So Fast"!

Our Q&A session after our third debate! Join the conversation at #HCCLive2024

Our incredible debate winners congratulations!

Dive into the Impact of Liver Function on Survival Outcomes! Join Arndt Vogel, MD/PhD, at the industry-sponsored event on Camrelizumab + Rivoceranib vs Sorafenib in uHCC Patients. Brought to you by Elevar Therapeutics #HCCLIVE2024

Best (and first for me) liver conference, & finally got to do a meeting w my good friend Amit G Singal! Learned a ton. Thanks so much to the HCC-LIVE Conference organizers! ☀️ 🏝️

Wrapping up #HCCLIVE2024! Join Amit Singal, MD, MS for our conference wrap up. We hope you enjoyed spending time with us this weekend and are taking home some valuable information! Looking forward to seeing you at HCC-LIVE 2025 in Austin, Texas!

Big shout out to the HCC-LIVE Conference organizers and course directors for creating a forum for truly multidisciplinary, high-end discussion as we continue to move forward in the fight against #HCC. So great to see old colleagues & make new connections. Looking forward to next year!

HCC-LIVE Conference was an outstanding conference! Thank you for welcoming #radonc. Fantastic passionate talks, Q&A & debates. The #SBRT debate was a wonderful way to end the meeting. Thx Amit G Singal for filling in last minute. ‘Look forward to collaborating to improve #HCC outcomes!

Reflecting on our annual HCC-LIVE Conference last week…Truly grateful to work with an amazing group of physician leaders who are making an impact every day through their various platforms. Feel like you’re missing out? Join the conversation Feb 20-22, 2025 in Austin, TX!!

Check out our new LinkedIn linkedin.com/company/hcc-li…. Make sure to follow to keep up with everything HCC Live! #Follow #LinkedIN #HCCLive